I would like to express our sincere appreciation to all our shareholders and investors for their continued understanding and support.
NanoCarrier will clarify its research and development priorities, urgently push ahead with development, and speed up out-licensing activities and applications for approval. We will also create new value through open innovation and help people lead healthier, happier lives.
We aim to quickly get results, not only to help patients, but also to enhance our corporate value so that our shareholders and investors are also satisfied.
We look forward to your continued support.
President & CEO
On this Website, NanoCarrier intends to provide audiences our financial information and operational results but make no representations or warranties to the information. Further, this Website is not an offer or a solicitation to buy or sell NanoCarrier’s securities. Please be aware that users must not rely on this information for investment decisions but decide on your own responsibility.
NanoCarrier will use reasonable efforts to include accurate and up-to-date information on this Website but in no event makes no warranties or representations of any kind as to its accuracy, currency or completeness, including alterations by third parties and damages by downloading data on this Website.
This Website contains forward-looking statements about NanoCarrier’s financial and operational performance. Actual results could differ materially, for example due to the change of business environment, from the expectations and projections set forth in those statements which include risks and uncertainties.
We may at any time interrupt, discontinue or change this Website without any notice. Conditions of your computer equipment or the network could prevent users from normal access or use of this Website. NanoCarrier shall not be liable for troubles, loss or damages arising out of your access to, or use of, this Website.